{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:36:37Z","timestamp":1793424997615,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005844","name":"Universitas Diponegoro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Congenital Adrenal Hyperplasia (CAH) due to CYP11B1 is a rare autosomal recessive adrenal disorder that causes a decrease in cortisol production and accumulation of adrenal androgens and steroid precursors with mineralocorticoid activity. Clinical manifestations include cortisol deficiency, ambiguous genitalia in females (differences of sex development (DSD)), and hypertension. Medical treatment recommendations are well defined, consisting of glucocorticoid treatment to substitute glucocorticoid deficiency and consequently normalize adrenal androgen and precursors levels. Current guidelines also emphasize the need for specialized multidisciplinary DSD teams and psychosocial support. In many developing countries, care for DSD patients, especially when caused by an adrenal disease, is challenging due to the lack of infrastructure, knowledge, and medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The study aims to report the conflicting decision-making process of medical treatment and sex assignment in late-identified CAH patients in developing countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We describe the clinical and biochemical findings and the psychological assessment of five affected but untreated family members with CAH due to CYP11B1 deficiency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All patients had a 46,XX karyotype, ambiguous genitalia, low cortisol levels, and hypertension. Two identified as males, two as females, and one had undecided gender. The patients were counselled that refusing treatment will lead to infertility and the potential risk of developing Addisonian crisis and severe hypertension. However, all 46,XX CAH males refused treatment with glucocorticoids due to the expected lowering of adrenal androgens as their main source of testosterone. None of the patients developed Addisonian crisis, probably due to some residual cortisol activity and glucocorticoid activity of elevated adrenal steroid precursors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Medical treatment and sex assignment in late-identified 46,XX CAH patients in Indonesia may often depend on local and cultural factors. The management of DSD conditions may have to be individualized and integrated into the psychological and social context of the affected family.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1015973","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T06:29:15Z","timestamp":1671085755000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country"],"prefix":"10.3389","volume":"13","author":[{"given":"Agustini","family":"Utari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultana M. H.","family":"Faradz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annastasia","family":"Ediati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahayu Dewi","family":"Ariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmad Zulfa","family":"Juniarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stenvert L. S.","family":"Drop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius E.","family":"van Herwaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi L.","family":"Claahsen-van der Grinten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2008.01.002","article-title":"Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia","volume":"19","author":"Nimkarn","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12834","article-title":"Characterization of the molecular genetic pathology in patients with 11beta-hydroxylase deficiency","volume":"83","author":"Mooij","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35389","article-title":"Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency","volume":"20","author":"Peter","year":"2002","journal-title":"Semin Reprod Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.17458\/PER.2016","article-title":"Disorders of adrenal steroidogenesis: Impact on gonadal function and sex development","volume":"14","author":"Mooij","year":"2016","journal-title":"Pediatr Endocrinol Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-017-0002-5","article-title":"Congenital adrenal hyperplasia causing hypertension: an illustrative review","volume":"32","author":"Hinz","year":"2018","journal-title":"J Hum Hypertens"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1621082114","article-title":"Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency","volume":"114","author":"Khattab","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijns6040076","article-title":"We all have a role to play: Redressing inequities for children living with CAH and other chronic health conditions of childhood in resource-poor settings","volume":"6","author":"Armstrong","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","article-title":"Host and environmental factors influencing individual human cytokine responses","volume":"167","author":"Ter Horst","year":"2016","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2521","article-title":"Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients","volume":"94","author":"Soardi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-008-9084-2","article-title":"Disorders of sex development (DSDs), their presentation and management in different cultures","volume":"9","author":"Warne","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30043-8","article-title":"Changing ethical and legal norms in the management of differences of sex development","volume":"5","author":"Sudai","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-1086-x","article-title":"Ethical principles and recommendations for the medical management of differences of sex development (DSD)\/intersex in children and adolescents","volume":"169","author":"Wiesemann","year":"2010","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1756287211428165","article-title":"Controversies on clitoroplasty","volume":"3","author":"Senayli","year":"2011","journal-title":"Ther Adv Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1087","article-title":"Adrenal steroid metabolites accumulating in congenital adrenal hyperplasia lead to transactivation of the glucocorticoid receptor","volume":"156","author":"Pijnenburg-Kleizen","year":"2015","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.03.033","article-title":"Long term outcomes in 46,XX adult patients with congenital adrenal hyperplasia reared as males","volume":"165","author":"Khattab","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"982025","DOI":"10.1186\/1687-9856-2010-982025","article-title":"Review of outcome information in 46,XX patients with congenital adrenal hyperplasia Assigned\/Reared Male: What does it say about gender assignment","volume":"2010","author":"Lee","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4158\/EP14179.CR","article-title":"Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation","volume":"20","author":"Bin-Abbas","year":"2014","journal-title":"Endocr Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-015-0493-5","article-title":"Gender development in Indonesian children, adolescents, and adults with disorders of sex development","volume":"44","author":"Ediati","year":"2015","journal-title":"Arch Sex Behav"},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jpsychores.2014.12.007","article-title":"Emotional and behavioral problems in late-identified Indonesian patients with disorders of sex development","volume":"79","author":"Ediati","year":"2015","journal-title":"J Psychosom Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2017-000130","article-title":"Social stigmatisation in late identified patients with disorders of sex development in Indonesia","volume":"1","author":"Ediati","year":"2017","journal-title":"BMJ Paediatr Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12955-020-01515-9","article-title":"Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia","volume":"18","author":"Zainuddin","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"B25","article-title":"A structured education program on hormonal control and quality of life in congenital adrenal hyperplasi: A study in Indonesia","author":"Utari","year":"2022"}],"updated-by":[{"DOI":"10.3389\/fendo.2023.1210892","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1015973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T09:14:21Z","timestamp":1683191661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1015973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":25,"alternative-id":["10.3389\/fendo.2022.1015973"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1015973","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fendo.2023.1210892","asserted-by":"object"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1015973"}}